We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Must Prep for Looming Metal Impurity Controls, Exec Urges
Drugmakers Must Prep for Looming Metal Impurity Controls, Exec Urges
April 6, 2012
Draft International Conference on Harmonisation (ICH) guidance set for release in June will tighten regulatory controls on metal impurities in finished drug products, but drugmakers should begin analyzing planned and marketed products now, a Pfizer official urges.